Latest / Clinical Guideline InSights
ASCP/CAP HER2 Testing & Clinical Decision Making in Gastroesophageal Adenocarcinoma 2026 Guideline
The 2026 HER2 Testing and Clinical Decision Making in Gastroesophageal Adenocarcinoma guideline, highlighting key recommendations and good practice statements across testing methods, the use immunohistochemistry with subsequent in-situ hybridization, specimen collection, and more.
HER2 Testing and Clinical Decision Making in Gastroesophageal Adenocarcinoma
American Society for Clinical Pathology (ASCP) / College of American Pathologists (CAP)
October 21, 2026
Guideline Summary: https://www.guidelinecentral.com/guideline/24275/
Full-Text…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.